"Fundada l'any 1900, MútuaTerrassa és una entitat de benefici social que té per missió el servei a les persones, anticipant i resolent situacions i problemes relacionats amb la salut, l'autonomia personal o el seu benestar. Actua en l'àmbit geogràfic fonamentalment de Catalunya i en algunes activitats a tot el territori espanyol."

During the past decade, Hospital Mutua de Terrassa Servicio de Oncologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Mutua de Terrassa Servicio de Oncologia" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Mutua de Terrassa Servicio de Oncologia" are "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Influenza A" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Mutua de Terrassa Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Mutua de Terrassa Servicio de Oncologia" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Capecitabine" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "Lapatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Mutua de Terrassa Servicio de Oncologia" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Mutua de Terrassa Servicio de Oncologia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Mutua de Terrassa Servicio de Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Mutua de Terrassa Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".